Loewe Kasprenski, MBA

Pharmaron Clinical Pharmacology Center (CPC)

Disclosure(s): TenNor Therapeutics (Suzhou) Ltd: Investigator

Poster(s):

• (P-1117) An Open-label Phase 1 Study in Healthy Adult Male Participants to Investigate the Absorption, Metabolism, and Excretion of [¹⁴C]-Rifaquizinone Following a Single Intravenous Administration
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT